Azitra, Inc. (AZTR) stock
AZTRNYSEPharmaceutical PreparationsFiscal year ends December 31
$0.57−0.04 (-6.20%)
Close on Nov 18, 2026Market cap $34.56MP/E –Yield –
Azitra net income
Net income is the profit left for shareholders after every expense, interest and tax.
Azitra's net income for the twelve months ending Jun 30, 2026 was -$12.27M. For fiscal 2025 it was -$10.96M.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$10.96M | – |
| FY2024 | Dec 31, 2024 | -$8.97M | – |
| FY2023 | Dec 31, 2023 | -$11.28M | – |
| FY2022 | Dec 31, 2022 | -$10.68M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$3.35M | – |
| Q1 FY2026 | Mar 31, 2026 | -$3.93M | – |
| Q4 FY2025 | Dec 31, 2025 | -$2.23M | – |
| Q3 FY2025 | Sep 30, 2025 | -$2.76M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.89M | – |
| Q1 FY2025 | Mar 31, 2025 | -$3.07M | – |
| Q4 FY2024 | Dec 31, 2024 | -$2.39M | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.01M | – |
| Q2 FY2024 | Jun 30, 2024 | -$2.63M | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.93M | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.45M | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.94M | – |
| Q2 FY2023 | Jun 30, 2023 | -$4.43M | – |
| Q1 FY2023 | Mar 31, 2023 | -$2.46M | – |
| Q4 FY2022 | Dec 31, 2022 | -$4.05M | – |
| Q3 FY2022 | Sep 30, 2022 | -$2.42M | – |
| Q2 FY2022 | Jun 30, 2022 | -$1.89M | – |
| Q1 FY2022 | Mar 31, 2022 | -$2.33M | – |
See a number that looks wrong?